These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 32413098)

  • 1. Deletion of inositol polyphosphate 4-phosphatase type-II B affects spermatogenesis in mice.
    Ceyhan Y; Zhang M; Guo J; Sandoval CG; Vacher J; Kaftanovskaya EM; Agoulnik AI; Agoulnik IU
    PLoS One; 2020; 15(5):e0233163. PubMed ID: 32413098
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inositol polyphosphate 4-phosphatase II regulates PI3K/Akt signaling and is lost in human basal-like breast cancers.
    Fedele CG; Ooms LM; Ho M; Vieusseux J; O'Toole SA; Millar EK; Lopez-Knowles E; Sriratana A; Gurung R; Baglietto L; Giles GG; Bailey CG; Rasko JE; Shields BJ; Price JT; Majerus PW; Sutherland RL; Tiganis T; McLean CA; Mitchell CA
    Proc Natl Acad Sci U S A; 2010 Dec; 107(51):22231-6. PubMed ID: 21127264
    [TBL] [Abstract][Full Text] [Related]  

  • 3. INPP4B and PTEN Loss Leads to PI-3,4-P2 Accumulation and Inhibition of PI3K in TNBC.
    Reed DE; Shokat KM
    Mol Cancer Res; 2017 Jun; 15(6):765-775. PubMed ID: 28196852
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inositol polyphosphate 4-phosphatase type II regulation of androgen receptor activity.
    Zhang M; Suarez E; Vasquez JL; Nathanson L; Peterson LE; Rajapakshe K; Basil P; Weigel NL; Coarfa C; Agoulnik IU
    Oncogene; 2019 Feb; 38(7):1121-1135. PubMed ID: 30228349
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The INPP4B paradox: Like PTEN, but different.
    Hamila SA; Ooms LM; Rodgers SJ; Mitchell CA
    Adv Biol Regul; 2021 Dec; 82():100817. PubMed ID: 34216856
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estrogen receptor β regulates AKT activity through up-regulation of INPP4B and inhibits migration of prostate cancer cell line PC-3.
    Chaurasiya S; Wu W; Strom AM; Warner M; Gustafsson JÅ
    Proc Natl Acad Sci U S A; 2020 Oct; 117(42):26347-26355. PubMed ID: 33020300
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decreased expression and androgen regulation of the tumor suppressor gene INPP4B in prostate cancer.
    Hodgson MC; Shao LJ; Frolov A; Li R; Peterson LE; Ayala G; Ittmann MM; Weigel NL; Agoulnik IU
    Cancer Res; 2011 Jan; 71(2):572-82. PubMed ID: 21224358
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence that inositol polyphosphate 4-phosphatase type II is a tumor suppressor that inhibits PI3K signaling.
    Gewinner C; Wang ZC; Richardson A; Teruya-Feldstein J; Etemadmoghadam D; Bowtell D; Barretina J; Lin WM; Rameh L; Salmena L; Pandolfi PP; Cantley LC
    Cancer Cell; 2009 Aug; 16(2):115-25. PubMed ID: 19647222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. INPP4B: the new kid on the PI3K block.
    Agoulnik IU; Hodgson MC; Bowden WA; Ittmann MM
    Oncotarget; 2011 Apr; 2(4):321-8. PubMed ID: 21487159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In Vivo Role of INPP4B in Tumor and Metastasis Suppression through Regulation of PI3K-AKT Signaling at Endosomes.
    Li Chew C; Lunardi A; Gulluni F; Ruan DT; Chen M; Salmena L; Nishino M; Papa A; Ng C; Fung J; Clohessy JG; Sasaki J; Sasaki T; Bronson RT; Hirsch E; Pandolfi PP
    Cancer Discov; 2015 Jul; 5(7):740-51. PubMed ID: 25883022
    [TBL] [Abstract][Full Text] [Related]  

  • 11. INPP4B Is a PtdIns(3,4,5)P3 Phosphatase That Can Act as a Tumor Suppressor.
    Kofuji S; Kimura H; Nakanishi H; Nanjo H; Takasuga S; Liu H; Eguchi S; Nakamura R; Itoh R; Ueno N; Asanuma K; Huang M; Koizumi A; Habuchi T; Yamazaki M; Suzuki A; Sasaki J; Sasaki T
    Cancer Discov; 2015 Jul; 5(7):730-9. PubMed ID: 25883023
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inositol polyphosphate-4-phosphatase type II and rucaparib treatment inhibit the growth of osteosarcoma cells dependent on phosphoinositide 3-kinase/protein kinase B pathway.
    Li D; Yang J; Ma H; Sun C; Feng R
    J Cell Biochem; 2018 Dec; 119(12):9899-9909. PubMed ID: 30132953
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determinants of the tumor suppressor INPP4B protein and lipid phosphatase activities.
    Lopez SM; Hodgson MC; Packianathan C; Bingol-Ozakpinar O; Uras F; Rosen BP; Agoulnik IU
    Biochem Biophys Res Commun; 2013 Oct; 440(2):277-82. PubMed ID: 24070612
    [TBL] [Abstract][Full Text] [Related]  

  • 14. INPP4B protects from metabolic syndrome and associated disorders.
    Zhang M; Ceyhan Y; Kaftanovskaya EM; Vasquez JL; Vacher J; Knop FK; Nathanson L; Agoulnik AI; Ittmann MM; Agoulnik IU
    Commun Biol; 2021 Mar; 4(1):416. PubMed ID: 33772116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A tumor suppressor function for the lipid phosphatase INPP4B in melanocytic neoplasms.
    Perez-Lorenzo R; Gill KZ; Shen CH; Zhao FX; Zheng B; Schulze HJ; Silvers DN; Brunner G; Horst BA
    J Invest Dermatol; 2014 May; 134(5):1359-1368. PubMed ID: 24288008
    [TBL] [Abstract][Full Text] [Related]  

  • 16. INPP4B restrains cell proliferation and metastasis via regulation of the PI3K/AKT/SGK pathway.
    Chen Y; Sun Z; Qi M; Wang X; Zhang W; Chen C; Liu J; Zhao W
    J Cell Mol Med; 2018 May; 22(5):2935-2943. PubMed ID: 29516642
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of INPP4B gene transfection combined with PARP inhibitor on castration therapy-resistant prostate cancer cell line, PC3.
    Ding H; Sun Y; Hou Y; Li L
    Urol Oncol; 2014 Jul; 32(5):720-6. PubMed ID: 24837011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of inositol polyphosphate 4-phosphatase type II as a novel tumor resistance biomarker in human laryngeal cancer HEp-2 cells.
    Kim JS; Yun HS; Um HD; Park JK; Lee KH; Kang CM; Lee SJ; Hwang SG
    Cancer Biol Ther; 2012 Nov; 13(13):1307-18. PubMed ID: 22895072
    [TBL] [Abstract][Full Text] [Related]  

  • 19. INPP4B-mediated tumor resistance is associated with modulation of glucose metabolism via hexokinase 2 regulation in laryngeal cancer cells.
    Min JW; Kim KI; Kim HA; Kim EK; Noh WC; Jeon HB; Cho DH; Oh JS; Park IC; Hwang SG; Kim JS
    Biochem Biophys Res Commun; 2013 Oct; 440(1):137-42. PubMed ID: 24051093
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of PI3K effector signalling in cancer by the phosphoinositide phosphatases.
    Rodgers SJ; Ferguson DT; Mitchell CA; Ooms LM
    Biosci Rep; 2017 Feb; 37(1):. PubMed ID: 28082369
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.